FDA
approval
· 2022-12-12
FDA Approved: TASIMELTEON — Original Application (Teva Pharmaceuticals, Inc.)
Summary
FDA approved tasimelteon under an original application for Teva Pharmaceuticals for the treatment of non-24-hour sleep-wake rhythm disorder in totally blind ind…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TASIMELTEON (TASIMELTEON)